Postoperative acute exacerbations in patients with idiopathic pulmonary fibrosis undergoing lung cancer surgery

Hasibe Çiğdem Erten; Sevda Şener  Cömert; Gonca Gül Geçmen; Talha  Doğruyol; Cihan  Akgül Özmen; Beyzanur  Ünver; Recep  Demirhan

doi:10.36141/svdld.2026.18641

Authors

Hasibe Çiğdem Erten University of Health Sciences Kartal Dr Lütfi Kırdar City Hospital
Sevda Şener Cömert Department of Pulmonary Medicine, University of Health Science, Kartal Dr. Lütfi Kırdar City Hospital, İstanbul, Turkey
Gonca Gül Geçmen Department of Pathology, University of Health Science, Kartal Dr. Lütfi Kırdar City Hospital, İstanbul, Turkey
Talha Doğruyol Department of Thoracic Surgery, University of Health Science, Kartal Dr. Lütfi Kırdar City Hospital, İstanbul, Turkey
Cihan Akgül Özmen Department of Radiology, University of Health Science, Kartal Dr. Lütfi Kırdar City Hospital, İstanbul, Turkey.
Beyzanur Ünver Department of Pulmonary Medicine, University of Health Science, Kartal Dr. Lütfi Kırdar City Hospital, İstanbul, Turkey
Recep Demirhan Department of Thoracic Surgery, University of Health Science, Kartal Dr. Lütfi Kırdar City Hospital, İstanbul, Turkey

Keywords:

Idiopathic pulmonary fibrosis, Lung neoplasms, Acute exacerbation, Postoperative complications, Thoracic surgery

Abstract

Background and aim: This study evaluated the incidence, risk factors, and mortality associated with postoperative acute exacerbations in IPF patients undergoing lung cancer surgery.

Methods: We retrospectively reviewed 1,225 lung cancer surgeries performed between 2018-2024, identifying 40 patients meeting ATS/ERS criteria for IPF. Acute exacerbations were defined as new bilateral ground-glass opacities superimposed on preexisting fibrosis within 30 days postoperatively. Clinical, radiological, functional, and pathological data were analyzed using univariate and multivariate logistic regression to identify risk factors for acute exacerbations and mortality.

Results: Postoperative acute exacerbations occurred in 15% (6/40) of patients, with 83.3% mortality within 30 days. Multivariate analysis confirmed lesion size >3cm (OR=3.50, 95%CI: 1.80-6.80, p<0.001), shorter IPF follow-up duration (OR=2.90, 95%CI: 1.50-5.70, p<0.001), and mortality (OR=0.026, 95%CI: 0.001-0.715, P=0.031) as independent risk factors. Overall mortality was 40%, significantly associated with preexisting emphysema (OR=6.998, 95%CI: 1.926-25.449, P=0.003) and long-term oxygen therapy (OR=5.845, 95%CI: 1.475-23.147, P=0.012).

Conclusions: Postoperative acute exacerbations are serious complications with high mortality in IPF patients undergoing lung cancer surgery. Tumor characteristics, particularly size and location, should guide preoperative risk assessment and perioperative management strategies.

References

1. Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis An Official ATS/ERS/JRS/ALAT Clinical practice guideline. Am J Respir Crit Care Med 2018;198(5):e44–e68.

2. Maher TM, Bendstrup E, Dron L, Langley J, Smith G, Khalid JM, et al. Global incidence and prevalence of idiopathic pulmonary fibrosis. Respir Res 2021;22(1):197.

3. Ballester B, Milara J, Cortijo J. Idiopathic pulmonary fibrosis and lung cancer: Mechanisms and molecular targets. Int. J. Mol. Sci.2019;20(3):593.

4. Homma S, Bando M, Azuma A, Sakamoto S, Sugino K, Ishii Y, et al. Japanese guideline for the treatment of idiopathic pulmonary fibrosis. Respir. Investig.2018;56(4):268-291.

5. Minegishi Y, Takenaka K, Mizutani H, Sudoh J, Noro R, Okano T, et al. Exacerbation of idiopathic interstitial pneumonias associated with lung cancer therapy. Internal Medicine 2009;48(9): 665–672.

6. Isobe K, Hata Y, Sakamoto S, Takai Y, Shibuya K, Homma S. Clinical characteristics of acute respiratory deterioration in pulmonary fibrosis associated with lung cancer following anti-cancer therapy. Respirology 2010;15(1):88-92.

7. Iyoda A, Jiang SX, Amano H, Ogawa F, Matui Y, Kurouzu N, et al. Prediction of postoperative exacerbation of interstitial pneumonia in patients with lung cancer and interstitial lung disease. Exp Ther Med 2011;2(6):1073-1076.

8. Patel AJ, Walters GI, Watkins S, Rogers V, Fallouh H, Kalkat M, et al. Lung cancer resection in patients with underlying usual interstitial pneumonia: A meta-analysis. BMJ Open Respir Res 2023;10(1):e001529.

9. Sato T, Kondo H, Watanabe A, Nakajima J, Niwa H, Horio H, et al. A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patients. Gen Thorac Cardiovasc Surg 2015;63(3):164-172.

10. Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Antoniou KM, Bissell BD, et al. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med 2022;205(9):e18-e47.

11. Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE, et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med.2007;176(7):265-275.

12. Rotman JA, Plodkowski AJ, Hayes SA, de Groot PM, Shepard JAO, Munden RF, et al. Postoperative complications after thoracic surgery for lung cancer. Clin. Imaging2015;39(5):735-749.

13. Van Schil PE, Rami-Porta R, Asamura H. The 8th TNM edition for lung cancer: a critical analysis. Ann Transl Med 2018;6(5):87.

14. Tjong MC, Mak DY, Shahi J, Li GJ, Chen H, Louie A V. Current Management and Progress in Radiotherapy for Small Cell Lung Cancer. Front. Oncol.2020;10:1146.

15. Sato T, Teramukai S, Kondo H, Watanabe A, Ebina M, Kishi K, et al. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. Journal of Thoracic and Cardiovascular Surgery 2014;147(5):1604-1611.

16. Taya T, Chiba H, Yamada G, Takahashi M, Ikeda K, Mori Y, et al. Risk factors for acute exacerbation of idiopathic interstitial pneumonia in patients undergoing lung cancer treatment. Jpn J Clin Oncol 2019;49(12):1126-1133.

17. Taniguchi D, Yamasaki N, Miyazaki T, Tsuchiya T, Matsumoto K, Hatachi G, et al. The surgical outcomes of lung cancer combined with interstitial pneumonia: a single-institution report. Surg Today 2017;47(11):1397-1404.

18. Saito Y, Kawai Y, Takahashi N, Ikeya T, Murai K, Kawabata Y, et al. Survival after surgery for pathologic stage IA non-small cell lung cancer associated with idiopathic pulmonary fibrosis. Annals of Thoracic Surgery 2011;92(5):1812-1817.

19. Mizuno Y, Iwata H, Shirahashi K, Takamochi K, Oh S, Suzuki K, et al. The importance of intraoperative fluid balance for the prevention of postoperative acute exacerbation of idiopathic pulmonary fibrosis after pulmonary resection for primary lung cancer. European Journal of Cardio-thoracic Surgery 2012;41(6):e161-e165.

20. Huang C, Sun YG, Ma C, Jiao P, Wu QJ, Tian WX, et al. Surgical outcomes and perioperative risk factors of patients with interstitial lung disease after pulmonary resection. J Cardiothorac Surg 2024;19(1):72.

21. Koizumi K, Hirata T, Hirai K, Mikami I, Okada D, Yamagishi S, et al. Surgical treatment of lung cancer combined with interstitial pneumonia: the effect of surgical approach on postoperative acute exacerbation. Ann Thorac Cardiovasc Surg 2004;10(6):340-346.

22. Tomassetti S, Gurioli C, Ryu JH, Decker PA, Ravaglia C, Tantalocco P, et al. The Impact of Lung Cancer on Survival of Idiopathic Pulmonary Fibrosis. Chest 2015;147(1):157–64:157-164.

23. Yano M, Sasaki H, Moriyama S, Hikosaka Y, Yokota K, Kobayashi S, et al. Post-operative acute exacerbation of pulmonary fibrosis in lung cancer patients undergoing lung resection. Interact Cardiovasc Thorac Surg 2012;14(2):146-150.

24. Hao X, Hao J, Chen C, Peng H, Zhang J, Cao Q, et al. Risk factors for acute exacerbation of interstitial lung disease following lung cancer resection: A systematic review and meta-Analysis. Interact. Cardiovasc. Thorac. Surg.2022;34(5):744-752.

25. Watanabe A, Miyajima M, Mishina T, Nakazawa J, Harada R, Kawaharada N, et al. Surgical treatment for primary lung cancer combined with idiopathic pulmonary fibrosis. Gen. Thorac. Cardiovasc. Surg.2013;61(5):254-261.